ViGeneron Announces FDA Clearance of IND for Novel mRNA Trans-Splicing Gene Therapy VG801 to Treat Stargardt Disease and Other ABCA4-Linked Retinal Dystrophies
18. Dezember 2024 08:00 ET
|
ViGeneron GmbH
VG801 is the first FDA IND clearance for novel mRNA trans-splicing gene therapy, delivering the full-length functional ABCA4 gene to target the genetic root cause of retinal dystrophies associated...
EyeDNA Therapeutics Receives Rare Pediatric Disease Designation from FDA for its Investigational Gene Therapy HORA-PDE6b for Patients with Retinal Dystrophy due to PDE6b Gene Mutations
17. Dezember 2024 06:00 ET
|
Coave Therapeutics
PDE6b-related Retinitis Pigmentosa is a rare inherited retinal dystrophy affecting up to 3,000 people in the US Symptoms often start in childhood leading to blindness by midlife with no approved...
AAVantgarde announces oral presentation of LUCE-1 clinical study at FLORetina 2024 annual meeting
03. Dezember 2024 02:00 ET
|
AAVantgarde Bio
AAVantgarde announces oral presentation of LUCE-1 clinical study at FLORetina 2024 annual meeting
AAVantgarde Bio Announces FDA Orphan Drug Designation for AAVB-081 for the Treatment of Usher Syndrome Type 1B Retinitis Pigmentosa
02. Dezember 2024 02:00 ET
|
AAVantgarde Bio
AAVantgarde Bio Announces FDA Orphan Drug Designation for AAVB-081 for the Treatment of Usher Syndrome Type 1B Retinitis Pigmentosa
AAVantgarde appoints Ms. Lauren Kaskiel as Chief Business Officer
21. Oktober 2024 02:00 ET
|
AAVantgarde Bio
AAVantgarde appoints Ms. Lauren Kaskiel as Chief Business Officer
EH216-S Pilotless eVTOL Completes First Flight in Brazil
24. September 2024 10:44 ET
|
EHang Holdings Limited
GUANGZHOU, China, Sept. 24, 2024 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading Urban Air Mobility (“UAM”) technology platform company, today...
AAVantgarde appoints Dr. Jayashree Sahni as Chief Medical Officer
09. September 2024 02:00 ET
|
AAVantgarde Bio
AAVantgarde appoints Dr. Jayashree Sahni as Chief Medical Officer
EHang Strongly Refutes False Allegations, Clarifies Misinformation Causing Stock Volatility
04. September 2024 12:39 ET
|
EHang Holdings Limited
GUANGZHOU, China, Sept. 04, 2024 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading urban air mobility (“UAM”) technology platform company, today...
EHang's Pilotless eVTOL Air Operator Certificate Application Accepted by CAAC
22. Juli 2024 10:30 ET
|
EHang Holdings Limited
GUANGZHOU, China, July 22, 2024 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading urban air mobility (“UAM”) technology platform company, today...
EHang Delivers 27 Units of EH216-S to Wencheng County and Completes First Passenger-Carrying Flight in Wencheng
25. Juni 2024 11:09 ET
|
EHang Holdings Limited
GUANGZHOU, China, June 25, 2024 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading urban air mobility (“UAM”) technology platform company,...